Quest for the right Drug
סופרן SUPRANE (DESFLURANE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
שאיפה : INHALATION
צורת מינון:
תמיסה לשאיפה : SOLUTION FOR INHALATION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Interactions : אינטראקציות
4.5 Interaction with other medicinal products and other forms of interaction Concentration of other gases The MAC for desflurane is reduced by concomitant N2O administration (see Table 1). Non-depolarizing and depolarizing muscle relaxants Commonly used muscle relaxants are potentiated by desflurane. Anaesthetic concentrations of desflurane at equilibrium reduce the ED95 of suxamethonium by approximately 30% and that of atracurium and pancuronium by approximately 50% compared to N2O/opioid anaesthesia. The doses of pancuronium, atracurium, suxamethonium and vecuronium needed to produce 95% (ED95) depression in neuromuscular transmission at different concentrations of desflurane are given in Table 2. With the exception of vecuronium, these doses are similar to isoflurane. The ED95 of vecuronium is 14% lower with desflurane than isoflurane. Additionally, recovery from neuromuscular blockade is longer with desflurane than with isoflurane. Table 2: Dosage (mg/kg) of muscle relaxant causing 95% depression in neuromuscular transmission Desflurane 6 Concentration Pancuronium Atracurium Suxamethonium Vecuronium 0.65 MAC/ 0.026 0.133 *NA *NA 60% N2O/O2 1.25 MAC/ 0.018 0.119 *NA *NA 60% N2O/O2 1.25 MAC/O2 0.022 0.120 0.362 0.019 100% O2 *NA = not available Pre-anaesthetic Drugs No clinically significant adverse interactions with commonly used pre-anaesthetic drugs, or drugs used during anaesthesia (intravenous agents, and local anaesthetic agents) were reported in clinical trials. The effect of desflurane on the disposition of other drugs has not been determined. Sedatives Patients anaesthetised with different concentrations of desflurane who received increasing doses of fentanyl showed a marked reduction in the anaesthetic requirements or MAC. The administration of increasing doses of intravenous midazolam showed a small reduction in MAC. Results are reported in Table 3. These MAC reductions are similar to those observed with isoflurane. It is anticipated that there will be a similar influence on MAC with other opioid and sedative drugs. 7 Table 3: Effect of Fentanyl or Midazolam on Desflurane MAC *MAC (%) %MAC Reduction No Fentanyl 6.33 - 6.35 - Fentanyl (3 mcg/kg) 3.12 - 3.46 46 - 51 Fentanyl (6 mcg/kg) 2.25 - 2.97 53 - 64 No Midazolam 5.85 - 6.86 - Midazolam (25 mcg/kg) 4.93 15.7 Midazolam (50 mcg/kg) 4.88 16.6 * Includes values for ages 18 - 65 years
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
רישום
101 32 28466 00
מחיר
0 ₪
מידע נוסף